Literature DB >> 21372741

Endothelial dysfunction, platelet activation, thrombogenesis and fibrinolysis in patients with hypertensive crisis.

Bert-Jan H van den Born1, Ester C Löwenberg, Niels V van der Hoeven, Bas de Laat, Joost C M Meijers, Marcel Levi, Gert A van Montfrans.   

Abstract

BACKGROUND: Hypertensive crisis is an extreme phenotype of hypertension and hypertension-related thrombotic complications. This is most evident in patients with hypertensive crisis having advanced retinopathy and thrombotic microangiopathy (TMA). We examined whether hypertensive crisis complicated by advanced retinopathy is associated with endothelial dysfunction, platelet activation, thrombin generation and decreased fibrinolytic activity. In addition, we tested the association between these procoagulant changes and the development of TMA and end-organ dysfunction.
METHODS: Several key mediators of coagulation were assessed in 40 patients with hypertensive crisis with and without retinopathy and compared with 20 age, sex and ethnicity-matched normotensive controls. In patients with hypertensive crisis, associations with markers of TMA and renal dysfunction were assessed by regression analysis.
RESULTS: Soluble P-selectin levels were higher in patients with hypertensive crisis compared with controls regardless of the presence or absence of retinopathy (P<0.01). Levels of von Willebrand factor (VWF), VWF propeptide, prothrombin fragment 1+2 (F1+2) and plasmin-antiplasmin (PAP) complexes were significantly higher in hypertensive crisis with retinopathy compared with normotensive controls (P-values<0.01), whereas in patients without retinopathy only VWF propeptide was higher (P=0.04). VWF, VWF propeptide, soluble tissue factor, F1+2 and PAP were positively associated with markers of TMA and renal dysfunction (P≤0.05).
CONCLUSION: Hypertensive crisis with retinopathy confers a prothrombotic state characterized by endothelial dysfunction, platelet activation and increased thrombin generation, whereas fibrinolytic activity is enhanced. The observed changes in prothrombotic and antithrombotic pathways may contribute to the increased risk of ischaemic and haemorrhagic complications in this extreme hypertension phenotype.
© 2011 Wolters Kluwer Health | Lippincott Williams & Wilkins

Entities:  

Mesh:

Year:  2011        PMID: 21372741     DOI: 10.1097/HJH.0b013e328345023d

Source DB:  PubMed          Journal:  J Hypertens        ISSN: 0263-6352            Impact factor:   4.844


  11 in total

Review 1.  Cardiovascular hypertensive emergencies.

Authors:  D P Papadopoulos; E A Sanidas; N A Viniou; V Gennimata; V Chantziara; I Barbetseas; T K Makris
Journal:  Curr Hypertens Rep       Date:  2015-02       Impact factor: 5.369

2.  Laminar Flow on Endothelial Cells Suppresses eNOS O-GlcNAcylation to Promote eNOS Activity.

Authors:  Sarah E Basehore; Samantha Bohlman; Callie Weber; Swathi Swaminathan; Yuji Zhang; Cholsoon Jang; Zoltan Arany; Alisa Morss Clyne
Journal:  Circ Res       Date:  2021-10-04       Impact factor: 17.367

Review 3.  Atypical hemolytic uremic syndrome in the setting of complement-amplifying conditions: case reports and a review of the evidence for treatment with eculizumab.

Authors:  Arif Asif; Ali Nayer; Christian S Haas
Journal:  J Nephrol       Date:  2016-11-15       Impact factor: 3.902

4.  Increased Von Willebrand factor, decreased ADAMTS13 and thrombocytopenia in melioidosis.

Authors:  Emma Birnie; Gavin C K W Koh; Ester C Löwenberg; Joost C M Meijers; Rapeephan R Maude; Nicholas P J Day; Sharon J Peacock; Tom van der Poll; W Joost Wiersinga
Journal:  PLoS Negl Trop Dis       Date:  2017-03-15

Review 5.  Cardiovascular Hypertensive Crisis: Recent Evidence and Review of the Literature.

Authors:  Christos Varounis; Vasiliki Katsi; Petros Nihoyannopoulos; John Lekakis; Dimitris Tousoulis
Journal:  Front Cardiovasc Med       Date:  2017-01-10

Review 6.  TTP-like syndrome: novel concept and molecular pathogenesis of endotheliopathy-associated vascular microthrombotic disease.

Authors:  Jae C Chang
Journal:  Thromb J       Date:  2018-08-11

Review 7.  Hypertensive Crisis in Acute Cerebrovascular Diseases Presenting at the Emergency Department: A Narrative Review.

Authors:  Mariagiovanna Cantone; Giuseppe Lanza; Valentina Puglisi; Luisa Vinciguerra; Jaime Mandelli; Francesco Fisicaro; Manuela Pennisi; Rita Bella; Rosella Ciurleo; Alessia Bramanti
Journal:  Brain Sci       Date:  2021-01-07

8.  Circulating microRNAs May Serve as Biomarkers for Hypertensive Emergency End-Organ Injuries and Address Underlying Pathways in an Animal Model.

Authors:  Knut Asbjørn Rise Langlo; Gustavo Jose Justo Silva; Tina Syvertsen Overrein; Volker Adams; Ulrik Wisløff; Håvard Dalen; Natale Rolim; Stein Ivar Hallan
Journal:  Front Cardiovasc Med       Date:  2021-02-12

9.  A case report of malignant hypertension in a young woman.

Authors:  Andrea Michelli; Stella Bernardi; Andrea Grillo; Emiliano Panizon; Matteo Rovina; Moreno Bardelli; Renzo Carretta; Bruno Fabris
Journal:  BMC Nephrol       Date:  2016-07-07       Impact factor: 2.388

10.  Clinical Determinants of Myocardial Injury, Detectable and Serial Troponin Levels among Patients with Hypertensive Crisis.

Authors:  Giancarlo Acosta; Ahmed Amro; Rodrigo Aguilar; Waiel Abusnina; Niharika Bhardwaj; George Augustine Koromia; Mark Studeny; Affan Irfan
Journal:  Cureus       Date:  2020-01-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.